Advisers to company CEO Elon Musk have reached out to major index providers seeking ways to secure earlier inclusion in ...

Whether or not this is the year that some of the biggest AI IPOs hit the public markets, there’s certainly a packed pipeline ...

Bob’s Discount Furniture Inc., a home furnishings retailer backed by Bain Capital, rose 0.1% in its trading debut after the ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to ...

Global funding for AI startups hit record levels in 2025, with European ones raising a record $21.6 billion, per Dealroom.

Generate Biomedicines’ IPO aims to fund Phase 3 GB-0895 for severe asthma/COPD and expand its pipeline. Learn more about GENB ...

Five IPOs are currently scheduled in the week ahead, and some smaller issuers may join the calendar throughout the week.

See if promising projects like IPO Genie, Ruvi AI, & Nexchain can keep up with new ZKP Crypto. Learn why credible analysts ...

The crypto and payment fintechs both debuted on the stock market in late January with strong openings, then traded down ahead ...

MapLight Therapeutics is heading to the Nasdaq this morning via a $250 million IPO the biotech will use to advance its challenger to Bristol Myers Squibb’s schizophrenia med Cobenfy. The ...

With an oversubscribed trading debut now in the books, Veradermics—developing an oral version of the molecule behind ...

The Bay Area had three IPOs on the calendar for this week, but that number was whittled down to 2 right at the buzzer.